Select Medical Holdings Corporation $SEM Position Boosted by JPMorgan Chase & Co.

JPMorgan Chase & Co. lifted its holdings in Select Medical Holdings Corporation (NYSE:SEM) by 24.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 554,203 shares of the health services provider’s stock after purchasing an additional 109,788 shares during the period. JPMorgan Chase & Co.’s holdings in Select Medical were worth $7,116,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in SEM. Quantbot Technologies LP bought a new stake in Select Medical during the third quarter worth approximately $27,000. MAI Capital Management increased its holdings in shares of Select Medical by 48,000.0% in the second quarter. MAI Capital Management now owns 2,405 shares of the health services provider’s stock valued at $37,000 after buying an additional 2,400 shares in the last quarter. Cornerstone Planning Group LLC lifted its position in shares of Select Medical by 6,868.4% during the 3rd quarter. Cornerstone Planning Group LLC now owns 3,972 shares of the health services provider’s stock valued at $51,000 after acquiring an additional 3,915 shares during the last quarter. Wilmington Savings Fund Society FSB boosted its stake in shares of Select Medical by 20.9% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 5,784 shares of the health services provider’s stock worth $74,000 after acquiring an additional 999 shares in the last quarter. Finally, Quadrant Capital Group LLC acquired a new position in shares of Select Medical in the 3rd quarter worth $93,000. 89.48% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on SEM shares. Benchmark lowered Select Medical from a “buy” rating to a “hold” rating in a research report on Wednesday, March 4th. Wall Street Zen cut Select Medical from a “buy” rating to a “hold” rating in a research note on Monday, March 9th. Zacks Research lowered shares of Select Medical from a “hold” rating to a “strong sell” rating in a research note on Thursday, February 26th. Weiss Ratings upgraded shares of Select Medical from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, February 20th. Finally, Royal Bank Of Canada reissued a “sector perform” rating and issued a $16.50 target price (down from $19.00) on shares of Select Medical in a research report on Tuesday, March 3rd. Two analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $15.63.

Select Medical Stock Performance

Shares of Select Medical stock opened at $16.30 on Tuesday. Select Medical Holdings Corporation has a 12 month low of $11.65 and a 12 month high of $18.60. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.89. The stock has a market cap of $2.02 billion, a PE ratio of 14.17, a price-to-earnings-growth ratio of 0.94 and a beta of 1.22. The business has a fifty day simple moving average of $15.76 and a 200-day simple moving average of $14.67.

Select Medical (NYSE:SEM) last posted its quarterly earnings results on Thursday, February 19th. The health services provider reported $0.16 earnings per share for the quarter, missing the consensus estimate of $0.23 by ($0.07). The business had revenue of $1.40 billion for the quarter, compared to analyst estimates of $1.36 billion. Select Medical had a net margin of 2.68% and a return on equity of 7.26%. The firm’s quarterly revenue was up 6.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.18 earnings per share. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. On average, sell-side analysts anticipate that Select Medical Holdings Corporation will post 1.17 EPS for the current fiscal year.

Select Medical Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, March 12th. Stockholders of record on Monday, March 2nd were given a $0.0625 dividend. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.5%. The ex-dividend date of this dividend was Monday, March 2nd. Select Medical’s dividend payout ratio is 21.74%.

Select Medical declared that its Board of Directors has approved a share buyback plan on Thursday, February 19th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the health services provider to repurchase up to 49.5% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s board believes its stock is undervalued.

About Select Medical

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.